Treating MDD with a Rapid-Acting Antidepressant That Modulates Both Glutamatergic and Monoaminergic Pathways

Overview

This branded symposium will highlight the current unmet needs in MDD and present a treatment option with rapid symptom improvement for adult patients with MDD.